lunes, 28 de febrero de 2022

CROI 2022 — 24-week all-oral regimens hold promise in rifampicin-resistant TB treatment

CROI 2022 — 24-week all-oral regimens hold promise in rifampicin-resistant TB treatment

No hay comentarios:

Publicar un comentario